VanEck Pharmaceutical ETF
109 hedge funds and large institutions have $393M invested in VanEck Pharmaceutical ETF in 2023 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 34 increasing their positions, 36 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
6% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 36
5.97% less ownership
Funds ownership: 94.67% → 88.69% (-6%)
72% less call options, than puts
Call options by funds: $1.16M | Put options by funds: $4.13M
Holders
109
Holding in Top 10
1
Calls
$1.16M
Puts
$4.13M
Top Buyers
| 1 | +$7.77M | |
| 2 | +$6.68M | |
| 3 | +$4.28M | |
| 4 |
IAA
Independent Advisor Alliance
Charlotte,
North Carolina
|
+$3.98M |
| 5 |
GIA
Gladstone Institutional Advisory
Palm Beach Gardens,
Florida
|
+$3.82M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$12.2M | |
| 3 | -$6.73M | |
| 4 |
JP Morgan Chase
New York
|
-$3.67M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$3.53M |